WO2024218193 - METHODS FOR IMPROVING INDIVIDUAL SERIAL DIAGNOSTIC TESTING

National phase entry:
Publication Number WO/2024/218193
Publication Date 24.10.2024
International Application No. PCT/EP2024/060497
International Filing Date 18.04.2024
Title **
[English] METHODS FOR IMPROVING INDIVIDUAL SERIAL DIAGNOSTIC TESTING
[French] PROCÉDÉS POUR AMÉLIORER DES TESTS DIAGNOSTIQUES INDIVIDUELS EN SÉRIE
Applicants **
RANDOX LABORATORIES LTD
Inventors
INNOCENZI, Paul John
FITZGERALD, Stephen Peter
MCCONNELL, Ivan
Priority Data
2305864.7   21.04.2023   GB
Application details
Total Number of Claims/PCT *
Number of Independent Claims *
Number of Priorities *
Number of Multi-Dependent Claims *
Number of Drawings *
Pages for Publication *
Number of Pages with Drawings *
Pages of Specification *
*
Number of Office Actions *
*
International Searching Authority
*
Recordal of a Change of the Applicant's Name/Address
*
Type of Assignment
*
Applicant's Legal Status
*
*
*
*
*
*
Entry into National Phase under
*
Patent Delivery
*
Translation

* The data is based on automatic recognition. Please verify and amend if necessary.

** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.

Quotation for National Phase entry

Country StagesTotal
China Filing, Examination, Granting2026
EPO Filing, Examination, Granting8131
Japan Filing, Examination, Granting2161
South Korea Filing, Examination, Granting2056
USA Filing, Examination, Granting4740
MasterCard Visa
Total: 19,114

The term for entry into the National Phase has expired. This quotation is for informational purposes only

Contact Us
Abstract[English] A method of supporting diagnostic decisions based on biochemical measurements is presented. The use of a correction factor derived from population biochemical measurement values when applied to a follow-on biochemical measurement value of an individual mitigates pre-analytical and analytical variation enabling more robust clinical analyses and decisions to be made.[French] L'invention concerne un procédé d'aide aux décisions diagnostiques sur la base de mesures biochimiques. L'utilisation d'un facteur de correction dérivé de valeurs de mesure biochimique de la population, lorsqu'il est appliqué à une valeur de mesure biochimique de suivi d'un individu atténue les variations pré-analytiques et analytiques, ce qui permet d'effectuer des analyses cliniques et de prendre des décisions cliniques plus solides.

Rejoining the server...